These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1071 related articles for article (PubMed ID: 25869468)

  • 1. Recent advancement of molecular mechanisms of liver fibrosis.
    Seki E; Brenner DA
    J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):512-8. PubMed ID: 25869468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis.
    de Oliveira da Silva B; Ramos LF; Moraes KCM
    Cell Biol Int; 2017 Sep; 41(9):946-959. PubMed ID: 28498509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets.
    Ezhilarasan D; Sokal E; Najimi M
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):192-197. PubMed ID: 29709350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells.
    Akkız H; Gieseler RK; Canbay A
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.
    Elpek GÖ
    World J Gastroenterol; 2014 Jun; 20(23):7260-76. PubMed ID: 24966597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taurine attenuates activation of hepatic stellate cells by inhibiting autophagy and inducing ferroptosis.
    Li S; Ren QJ; Xie CH; Cui Y; Xu LT; Wang YD; Li S; Liang XQ; Wen B; Liang MK; Zhao XF
    World J Gastroenterol; 2024 Apr; 30(15):2143-2154. PubMed ID: 38681990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin of myofibroblasts in the fibrotic liver in mice.
    Iwaisako K; Jiang C; Zhang M; Cong M; Moore-Morris TJ; Park TJ; Liu X; Xu J; Wang P; Paik YH; Meng F; Asagiri M; Murray LA; Hofmann AF; Iida T; Glass CK; Brenner DA; Kisseleva T
    Proc Natl Acad Sci U S A; 2014 Aug; 111(32):E3297-305. PubMed ID: 25074909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of the Wnt antagonist Dkk2 links the loss of Sept4 and myofibroblastic transformation of hepatic stellate cells.
    Yanagida A; Iwaisako K; Hatano E; Taura K; Sato F; Narita M; Nagata H; Asechi H; Uemoto S; Kinoshita M
    Biochim Biophys Acta; 2011 Nov; 1812(11):1403-11. PubMed ID: 21763422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
    Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
    Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of liver cirrhosis: current evidence and expectations.
    Jung YK; Yim HJ
    Korean J Intern Med; 2017 Mar; 32(2):213-228. PubMed ID: 28171717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
    Carloni V; Luong TV; Rombouts K
    Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.
    Taura K; De Minicis S; Seki E; Hatano E; Iwaisako K; Osterreicher CH; Kodama Y; Miura K; Ikai I; Uemoto S; Brenner DA
    Gastroenterology; 2008 Nov; 135(5):1729-38. PubMed ID: 18823985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New therapies for hepatic fibrosis.
    Koyama Y; Brenner DA
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1(0 1):S75-9. PubMed ID: 26206573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrosis in the liver: acute protection and chronic disease.
    Lee Y; Friedman SL
    Prog Mol Biol Transl Sci; 2010; 97():151-200. PubMed ID: 21074733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic stellate cells role in the course of metabolic disorders development - A molecular overview.
    Bourebaba N; Marycz K
    Pharmacol Res; 2021 Aug; 170():105739. PubMed ID: 34171492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The origin of fibrogenic myofibroblasts in fibrotic liver.
    Kisseleva T
    Hepatology; 2017 Mar; 65(3):1039-1043. PubMed ID: 27859502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet?
    Lucantoni F; Martínez-Cerezuela A; Gruevska A; Moragrega ÁB; Víctor VM; Esplugues JV; Blas-García A; Apostolova N
    J Pathol; 2021 Jul; 254(3):216-228. PubMed ID: 33834482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.
    Tan Z; Qian X; Jiang R; Liu Q; Wang Y; Chen C; Wang X; Ryffel B; Sun B
    J Immunol; 2013 Aug; 191(4):1835-44. PubMed ID: 23842754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxin in hepatic fibrosis: What is known and where to head?
    Ezhilarasan D
    Biochimie; 2021 Aug; 187():144-151. PubMed ID: 34102254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis.
    Iwaisako K; Brenner DA; Kisseleva T
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):65-8. PubMed ID: 22320919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.